Teva Pharmaceuticals USA is recalling approximately 64,978 patches of Clonidine Transdermal System (clonidine), USP 0.1 mg/day, a prescription medication used to treat high blood pressure. This recall was initiated because the product failed to meet quality specifications for impurities and degradation during testing. No incidents or injuries have been reported in connection with this recall. The medication was distributed in 4-count cartons through pharmacies nationwide and in Puerto Rico.
The product failed to meet chemical impurity and degradation standards, which can impact the stability and safety of the medication. Using medication that has degraded or contains excessive impurities may result in a lack of efficacy or unexpected side effects.
You have 2 options:
Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT; Distributed by: Actavis Pharma, Inc., Parsippany, NJ
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.